Context matters: the evolving use of biomarkers in Alzheimer's disease care.
作者信息
Fortea Juan
机构信息
Sant Pau Memory Unit, Institut de Recerca Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Catalan Down Syndrome Foundation, Barcelona, Spain.
出版信息
EBioMedicine. 2024 Oct;108:105387. doi: 10.1016/j.ebiom.2024.105387. Epub 2024 Oct 3.
Abstract
摘要
相似文献
1
Context matters: the evolving use of biomarkers in Alzheimer's disease care.背景很重要：阿尔茨海默病护理中生物标志物的应用不断演变。
EBioMedicine. 2024 Oct;108:105387. doi: 10.1016/j.ebiom.2024.105387. Epub 2024 Oct 3.
2
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.阿尔茨海默病中的 Tau 生物标志物：迈向临床实践和试验的应用。
Lancet Neurol. 2022 Aug;21(8):726-734. doi: 10.1016/S1474-4422(22)00168-5. Epub 2022 May 25.
3
Biomarkers in Alzheimer's disease.阿尔茨海默病中的生物标志物。
Neurobiol Aging. 1998 Mar-Apr;19(2):159-60. doi: 10.1016/s0197-4580(98)00017-7.
4
Biomarkers for Alzheimer's disease: showing the way or leading us astray?阿尔茨海默病的生物标志物：指明道路还是误导我们？
J Alzheimers Dis. 2013;33 Suppl 1(Suppl 1):S371-6. doi: 10.3233/JAD-2012-129022.
5
Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer's disease and Down syndrome.常染色体显性阿尔茨海默病和唐氏综合征中体液生物标志物的临床和研究应用。
EBioMedicine. 2024 Oct;108:105327. doi: 10.1016/j.ebiom.2024.105327. Epub 2024 Oct 3.
6
Biological markers of Alzheimer's disease.阿尔茨海默病的生物标志物。
Neurobiol Aging. 1998 Mar-Apr;19(2):149-51. doi: 10.1016/s0197-4580(98)00010-4.
7
Methodological and research issues in the evaluation of biological diagnostic markers for Alzheimer's disease.阿尔茨海默病生物学诊断标志物评估中的方法学与研究问题
Neurobiol Aging. 1998 Mar-Apr;19(2):121-3. doi: 10.1016/s0197-4580(98)00019-0.
8
Biomarkers in the diagnosis and prognosis of Alzheimer's disease.阿尔茨海默病诊断与预后中的生物标志物
J Neurol. 2020 Aug;267(8):2475-2477. doi: 10.1007/s00415-020-10037-9.
9
Spitting image: can saliva biomarkers reflect Alzheimer's disease?酷似的形象：唾液生物标志物能反映阿尔茨海默病吗？
EBioMedicine. 2021 Jun;68:103437. doi: 10.1016/j.ebiom.2021.103437. Epub 2021 Jun 13.
10
Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.阿尔茨海默病的诊断与治疗：过去、现在和未来的伦理问题。
Prog Neurobiol. 2013 Nov;110:102-13. doi: 10.1016/j.pneurobio.2013.01.003. Epub 2013 Apr 8.
引用本文的文献
1
The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery.唐氏综合征巴塞罗那神经影像倡议组织（DABNI）及其对理解唐氏综合征中的阿尔茨海默病的贡献：十年探索成果
Alzheimers Dement. 2025 Jun;21(6):e70259. doi: 10.1002/alz.70259.
本文引用的文献
1
Use of biomarkers in the diagnosis of Alzheimer's disease in adults with intellectual disability.在成年智力障碍患者中使用生物标志物诊断阿尔茨海默病。
Lancet Healthy Longev. 2024 Oct;5(10):100639. doi: 10.1016/j.lanhl.2024.100639. Epub 2024 Oct 3.
2
Challenges in the practical implementation of blood biomarkers for Alzheimer's disease.阿尔茨海默病血液生物标志物实际应用中的挑战。
Lancet Healthy Longev. 2024 Oct;5(10):100630. doi: 10.1016/j.lanhl.2024.07.013. Epub 2024 Oct 3.
3
Biomarkers of neurodegeneration across the Global South.全球南方的神经退行性变生物标志物。
Lancet Healthy Longev. 2024 Oct;5(10):100616. doi: 10.1016/S2666-7568(24)00132-6. Epub 2024 Oct 3.
4
Insights into the use of biomarkers in clinical trials in Alzheimer's disease.浅析生物标志物在阿尔茨海默病临床试验中的应用。
EBioMedicine. 2024 Oct;108:105322. doi: 10.1016/j.ebiom.2024.105322. Epub 2024 Oct 3.
5
Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer's disease and Down syndrome.常染色体显性阿尔茨海默病和唐氏综合征中体液生物标志物的临床和研究应用。
EBioMedicine. 2024 Oct;108:105327. doi: 10.1016/j.ebiom.2024.105327. Epub 2024 Oct 3.
6
Alzheimer's disease biomarkers and the tyranny of treatment.阿尔茨海默病生物标志物与治疗的暴政。
EBioMedicine. 2024 Oct;108:105291. doi: 10.1016/j.ebiom.2024.105291. Epub 2024 Oct 3.
7
Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study.唐氏综合征成人患者的血浆和脑脊液神经胶质纤维酸性蛋白水平：一项纵向队列研究。
EBioMedicine. 2023 Apr;90:104547. doi: 10.1016/j.ebiom.2023.104547. Epub 2023 Mar 30.
8
Blood Biomarkers in Neurodegenerative Diseases: Implications for the Clinical Neurologist.神经退行性疾病中的血液生物标志物：对临床神经科医生的影响。
Neurology. 2023 Jul 25;101(4):172-180. doi: 10.1212/WNL.0000000000207193. Epub 2023 Mar 6.
9
Interactive visualisation for interpreting diagnostic test accuracy study results.交互式可视化用于解释诊断性测试准确性研究结果。
BMJ Evid Based Med. 2018 Feb;23(1):13-16. doi: 10.1136/ebmed-2017-110862.
10
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.A/T/N：阿尔茨海默病生物标志物的无偏描述性分类方案。
Neurology. 2016 Aug 2;87(5):539-47. doi: 10.1212/WNL.0000000000002923. Epub 2016 Jul 1.
Zotero 插件